Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for cognitive impairment in Parkinson's disease
ChiCTR1800017084Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of butylphthalide in Parkinson's disease (PD) (2 arms), sponsored by Union Hospital. Primary endpoints: Mini-Mental State Examination and Montreal Cognitive Assessment. Started May 2018; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR1800017084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017084.